Published online before print June 17, 2002, doi: 10.1161/01.CIR.0000021426.87274.62
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:254.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II
From the Department of Cardiology and Angiology (A.H., D.H.-K., M.F., K.K., B.S., H.D.), Department of Cardiovascular Surgery (A.L.), and Center of Anatomy (H.-J.R.), Medizinische Hochschule Hannover, Germany.
Correspondence to Helmut Drexler, MD, Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Carl Neuberg Straße 1, 30625 Hannover, Germany. E-mail drexler.helmut{at}mh-hannover.de
Background— The renin-angiotensin system is thought to be involved in development and progression of arteriosclerosis, thereby contributing to adverse cardiovascular events. To elucidate the role of angiotensin II (Ang II) at a cellular level, we analyzed the Ang II–induced gene expression profile.
Methods and Results— Genes induced on Ang II stimulation (10-7 mol/L, 45 minutes) in rat smooth muscle cells were analyzed by polymerase chain reaction selected subtraction. In addition to known genes, such as interleukin 6, leukemia inhibitory factor, and c-fos, we identified CYR61, an angiogenic immediate early gene. Northern blot analysis revealed a rapid 2.5-fold increase of CYR61 transcript levels by Ang II, peaking at 30 minutes, which was blunted by Ang II type 1 receptor blockade. Exposure of rat aortic rings to Ang II (30 minutes) revealed a 2-fold, and intraperitoneal injection of Ang II (30 minutes) in mice a 3-fold, increase of aortic CYR61 transcripts. In arteriosclerotic aortas of apolipoprotein E–deficient mice, CYR61 transcripts confirmed by in situ hybridization and proteins shown by immunohistochemistry were elevated, whereas they were hardly detectable in wild types. In human carotid atherectomies and arteriosclerotic coronary arteries, immunohistochemical analysis revealed expression of CYR61 within connective tissue in neointima, adventitia, and surrounding small capillaries and blood vessels, colocalized with ACE and Ang II. Normal human arteries showed no significant staining for CYR61.
Conclusions— CYR61, an angiogenic factor, is induced by Ang II in vascular cells and tissue. The expression of CYR61, colocalized with Ang II and ACE, in small vessels of human arteriosclerotic lesions is consistent with the notion that the activated renin-angiotensin system may contribute to plaque neovascularization by enhancing regulators of microvessel formation and cell proliferation.
Key Words: angiotensin • arteriosclerosis • arteries • genes • stenosis
This article has been cited by other articles:
 |
|
 |
|
  H. Matsumae, Y. Yoshida, K. Ono, K. Togi, K. Inoue, Y. Furukawa, Y. Nakashima, Y. Kojima, M. Nobuyoshi, T. Kita, et al. CCN1 Knockdown Suppresses Neointimal Hyperplasia in a Rat Artery Balloon Injury Model Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1077 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Papanicolaou, Y. Izumiya, and K. Walsh Forkhead Transcription Factors and Cardiovascular Biology Circ. Res., January 4, 2008; 102(1): 16 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Grote, G. Salguero, M. Ballmaier, M. Dangers, H. Drexler, and B. Schieffer The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration Blood, August 1, 2007; 110(3): 877 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Lee, J.-W. Chung, S.-W. Youn, J.-Y. Kim, K.-W. Park, B.-K. Koo, B.-H. Oh, Y.-B. Park, B. Chaqour, K. Walsh, et al. Forkhead Transcription Factor FOXO3a Is a Negative Regulator of Angiogenic Immediate Early Gene CYR61, Leading to Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia Circ. Res., February 16, 2007; 100(3): 372 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lichtenberg, I. Tudorache, S. Cebotari, M. Suprunov, G. Tudorache, H. Goerler, J.-K. Park, D. Hilfiker-Kleiner, S. Ringes-Lichtenberg, M. Karck, et al. Preclinical Testing of Tissue-Engineered Heart Valves Re-Endothelialized Under Simulated Physiological Conditions Circulation, July 4, 2006; 114(1_suppl): I-559 - I-565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hilfiker-Kleiner, A. Hilfiker, M. Castellazzi, K. C. Wollert, C. Trautwein, H. Schunkert, and H. Drexler JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity Cardiovasc Res, July 1, 2006; 71(1): 108 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cheng, D. Tempel, R. van Haperen, A. van der Baan, F. Grosveld, M. J.A.P. Daemen, R. Krams, and R. de Crom Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress Circulation, June 13, 2006; 113(23): 2744 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Yakubenko, S. P. Yadav, and T. P. Ugarova Integrin {alpha}Dbeta2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties Blood, February 15, 2006; 107(4): 1643 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. R. Pendurthi, T. T. Tran, M. Post, and L. V. M. Rao Proteolysis of CCN1 by Plasmin: Functional Implications Cancer Res., November 1, 2005; 65(21): 9705 - 9711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hilfiker-Kleiner, A. Hilfiker, K. Kaminski, A. Schaefer, J.-K. Park, K. Michel, A. Quint, M. Yaniv, J. B. Weitzman, and H. Drexler Lack of JunD Promotes Pressure Overload-Induced Apoptosis, Hypertrophic Growth, and Angiogenesis in the Heart Circulation, September 6, 2005; 112(10): 1470 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Cicha, A. Yilmaz, M. Klein, D. Raithel, D. R. Brigstock, W. G. Daniel, M. Goppelt-Struebe, and C. D. Garlichs Connective Tissue Growth Factor Is Overexpressed in Complicated Atherosclerotic Plaques and Induces Mononuclear Cell Chemotaxis In Vitro Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1008 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Klein, A. Schaefer, D. Hilfiker-Kleiner, D. Oppermann, P. Shukla, A. Quint, E. Podewski, A. Hilfiker, F. Schroder, M. Leitges, et al. Increased Collagen Deposition and Diastolic Dysfunction but Preserved Myocardial Hypertrophy After Pressure Overload in Mice Lacking PKC{epsilon} Circ. Res., April 15, 2005; 96(7): 748 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. M. Rao and U. R. Pendurthi Tissue Factor-Factor VIIa Signaling Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 47 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Grote, U. Bavendiek, C. Grothusen, I. Flach, D. Hilfiker-Kleiner, H. Drexler, and B. Schieffer Stretch-inducible Expression of the Angiogenic Factor CCN1 in Vascular Smooth Muscle Cells Is Mediated by Egr-1 J. Biol. Chem., December 31, 2004; 279(53): 55675 - 55681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Stolle, B. Weitkamp, J. Rauterberg, S. Lorkowski, and P. Cullen Laser Microdissection-based Analysis of mRNA Expression in Human Coronary Arteries with Intimal Thickening J. Histochem. Cytochem., November 1, 2004; 52(11): 1511 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Chen, S.-J. Leu, V. Todorovic, S. C.-T. Lam, and L. F. Lau Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells J. Biol. Chem., October 15, 2004; 279(42): 44166 - 44176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Leu, N. Chen, C.-C. Chen, V. Todorovic, T. Bai, V. Juric, Y. Liu, G. Yan, S. C.-T. Lam, and L. F. Lau Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61): SELECTIVE INACTIVATION OF INTEGRIN {alpha}6{beta}1-HEPARAN SULFATE PROTEOGLYCAN CORECEPTOR-MEDIATED CELLULAR FUNCTIONS J. Biol. Chem., October 15, 2004; 279(42): 44177 - 44187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sakamoto, M. Yokoyama, X. Zhang, K. Prakash, K. Nagao, T. Hatanaka, R. H. Getzenberg, and Y. Kakehi Increased Expression of CYR61, an Extracellular Matrix Signaling Protein, in Human Benign Prostatic Hyperplasia and Its Regulation by Lysophosphatidic Acid Endocrinology, June 1, 2004; 145(6): 2929 - 2940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hilfiker-Kleiner, K. Kaminski, A. Kaminska, M. Fuchs, G. Klein, E. Podewski, K. Grote, I. Kiian, K. C. Wollert, A. Hilfiker, et al. Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation Circulation, May 11, 2004; 109(18): 2227 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sakamoto, M. Yokoyama, K. Prakash, J.-I. Tsuruha, S. Masamoto, R. H. Getzenberg, and Y. Kakehi Development of Quantitative Detection Assays for CYR61 as a New Marker for Benign Prostatic Hyperplasia J Biomol Screen, December 1, 2003; 8(6): 701 - 711. [Abstract] [PDF]
|
|
|
|
 |
|
 Y.-W. Chen, M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson Molecular responses of human muscle to eccentric exercise J Appl Physiol, December 1, 2003; 95(6): 2485 - 2494. [Abstract] [Full Text]
|
|
|
|
|
|
S.-J. Leu, Y. Liu, N. Chen, C.-C. Chen, S. C.-T. Lam, and L. F. Lau Identification of a Novel Integrin {alpha}6{beta}1 Binding Site in the Angiogenic Inducer CCN1 (CYR61) J. Biol. Chem., September 5, 2003; 278(36): 33801 - 33808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Xiao, S. Fuchs, K. Frenzel, J. M. Cole, and K. E. Bernstein Newer Approaches to Genetic Modeling in Mice: Tissue-Specific Protein Expression as Studied Using Angiotensin-Converting Enzyme (ACE) Am. J. Pathol., September 1, 2003; 163(3): 807 - 817. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Schober, L. F. Lau, T. P. Ugarova, and S. C.-T. Lam Identification of a Novel Integrin {alpha}M{beta}2 Binding Site in CCN1 (CYR61), a Matricellular Protein Expressed in Healing Wounds and Atherosclerotic Lesions J. Biol. Chem., July 3, 2003; 278(28): 25808 - 25815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sawai, K. Mori, M. Mukoyama, A. Sugawara, T. Suganami, M. Koshikawa, K. Yahata, H. Makino, T. Nagae, Y. Fujinaga, et al. Angiogenic Protein Cyr61 is Expressed by Podocytes in Anti-Thy-1 Glomerulonephritis J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1154 - 1163. [Abstract] [Full Text] [PDF]
|
|